APA (7th ed.) Citation

E, B., M, A., MR, T., CJ, P., & J, B. (2026). Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target. Current atherosclerosis reports, 28(1), 22. https://doi.org/10.1007/s11883-026-01399-y

Chicago Style (17th ed.) Citation

E, Björnson, Adiels M, Taskinen MR, Packard CJ, and Borén J. "Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target." Current Atherosclerosis Reports 28, no. 1 (2026): 22. https://doi.org/10.1007/s11883-026-01399-y.

MLA (9th ed.) Citation

E, Björnson, et al. "Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target." Current Atherosclerosis Reports, vol. 28, no. 1, 2026, p. 22, https://doi.org/10.1007/s11883-026-01399-y.